NCT04341103View on ClinicalTrials.gov

AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

March 1, 2021

Conditions
Solid Organ Transplant RejectionCOVID-19
Sponsors

Lead Sponsor

CareDx
All Listed Sponsors
lead

CareDx

INDUSTRY

NCT04341103 - AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience | Biotech Hunter | Biotech Hunter